Literature DB >> 33403166

Bilateral Foot-Drop Secondary to Axonal Neuropathy in a Tuberculosis Patient With Co-Infection of COVID-19: A Case Report.

Mohammad H AlKhateeb1, Afia Aziz1, Mugahid Eltahir1, Abdulnasser Elzouki1.   

Abstract

Tuberculosis (TB) is a global pandemic and is one of the top 10 causes of death worldwide as well as the leading cause of death from a single infectious agent. It can cause a wide array of complications including peripheral neuropathy. In addition to TB pandemic the recent pandemic of coronavirus disease 2019 (COVID-19) has led to an increased interest in the co-infection of TB patients and COVID-19 and whether TB increases risk for COVID-19 and its role in causing severity of disease and vice-versa. This case report discusses about a young cachectic man who was found to have bilateral foot-drop under the setting of TB with co-infection of COVID-19 later confirmed to be axonal neuropathy on nerve conduction study. The report highlights the importance of differential diagnosis of TB in COVID-19 patients as well as the consideration of TB in a patient with peripheral neuropathy after nutritional causes have been ruled out.
Copyright © 2020, AlKhateeb et al.

Entities:  

Keywords:  covid-19; foot drop; novel coronavirus; peripheral neuropathy; sars-cov-2 infection; tuberculosis

Year:  2020        PMID: 33403166      PMCID: PMC7773300          DOI: 10.7759/cureus.11734

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  18 in total

Review 1.  Tuberculosis of spine: neurological deficit.

Authors:  Anil K Jain; Jaswant Kumar
Journal:  Eur Spine J       Date:  2012-05-08       Impact factor: 3.134

2.  Severe COVID-19 cases with a history of active or latent tuberculosis.

Authors:  C Liu; Y Yu; J Fleming; T Wang; S Shen; Y Wang; L Fan; J Ma; Y Gu; Y Chen
Journal:  Int J Tuberc Lung Dis       Date:  2020-07-01       Impact factor: 2.373

3.  Peripheral nerve granuloma in a patient with tuberculosis.

Authors:  R W Orrell; R H M King; J V Bowler; L Ginsberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

4.  Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19.

Authors:  Karla Therese L Sy; Nel Jason L Haw; Jhanna Uy
Journal:  Infect Dis (Lond)       Date:  2020-08-18

5.  Tuberculous neuritis: a rare sequel of a common disease.

Authors:  Bhushan M Warpe; Sandhya V Poflee; Nandu P Pande; Anuradha V Shrikhande
Journal:  Indian J Pathol Microbiol       Date:  2014 Jan-Mar       Impact factor: 0.740

6.  COVID-19 and TB co-infection - 'Finishing touch'' in perfect recipe to 'severity' or 'death'.

Authors:  Dr Rohit Kumar; Dr Bisakh Bhattacharya; Dr Vedprakash Meena; Dr Manish Soneja; Dr Naveet Wig
Journal:  J Infect       Date:  2020-06-29       Impact factor: 6.072

Review 7.  Peripheral neuropathy in persons with tuberculosis.

Authors:  Arnold T Mafukidze; Marianne Calnan; Jennifer Furin
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2015-12-03

8.  Four Patients with COVID-19 and Tuberculosis, Singapore, April-May 2020.

Authors:  Sai Meng Tham; Wei Yang Lim; Chun Kiat Lee; Jerold Loh; Arthi Premkumar; Benedict Yan; Adrian Kee; Louis Chai; Paul Anantharajah Tambyah; Gabriel Yan
Journal:  Emerg Infect Dis       Date:  2020-07-15       Impact factor: 6.883

9.  Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital.

Authors:  Claudia Stochino; Simone Villa; Patrizia Zucchi; Pierpaolo Parravicini; Andrea Gori; Mario Carlo Raviglione
Journal:  Eur Respir J       Date:  2020-06-01       Impact factor: 16.671

10.  A profile of a retrospective cohort of 22 patients with COVID-19 and active/treated tuberculosis.

Authors:  Nitesh Gupta; Pranav Ish; Amitesh Gupta; Nipun Malhotra; Jose Antonio Caminero; Rupak Singla; Rohit Kumar; Siddharth Raj Yadav; Nishanth Dev; Sumita Agrawal; Santvana Kohli; M K Sen; Shibdas Chakrabarti; N K Gupta
Journal:  Eur Respir J       Date:  2020-11-19       Impact factor: 16.671

View more
  5 in total

Review 1.  Clinical Characteristics, Diagnosis, Treatment, and Mortality Rate of TB/COVID-19 Coinfectetd Patients: A Systematic Review.

Authors:  Maryam Koupaei; Adel Naimi; Narges Moafi; Paria Mohammadi; Faezeh Sadat Tabatabaei; Soroosh Ghazizadeh; Mohsen Heidary; Saeed Khoshnood
Journal:  Front Med (Lausanne)       Date:  2021-12-01

Review 2.  Mycobacterium tuberculosis and SARS-CoV-2 Coinfections: A Review.

Authors:  Narjess Bostanghadiri; Faramarz Masjedian Jazi; Shabnam Razavi; Lanfranco Fattorini; Davood Darban-Sarokhalil
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

3.  Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection: a systematic review and meta-analysis (from November 2019 to March 2021).

Authors:  Quan Wang; Shasha Guo; Xiaolin Wei; Quanfang Dong; Ning Xu; Hui Li; Jie Zhao; Qiang Sun
Journal:  BMJ Open       Date:  2022-06-20       Impact factor: 3.006

Review 4.  Clinical Features and Treatment Outcome of Coronavirus and Tuberculosis Co-Infected Patients: A Systematic Review of Case Reports.

Authors:  Hilina Mollalign; Dawit Chala; Dereje Beyene
Journal:  Infect Drug Resist       Date:  2022-07-27       Impact factor: 4.177

Review 5.  Clinical Outcomes of Individuals with COVID-19 and Tuberculosis during the Pre-Vaccination Period of the Pandemic: A Systematic Review.

Authors:  Tulip A Jhaveri; Celia Fung; Allison N LaHood; Andrew Lindeborg; Chengbo Zeng; Rifat Rahman; Paul A Bain; Gustavo E Velásquez; Carole D Mitnick
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.